Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2006
08/02/2006EP1684810A1 Polybiotin compounds for magnetic resonance imagining and drug delivery
08/02/2006EP1684779A1 Method for controlling angiogenesis in animals
08/02/2006EP1578416B1 Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles
08/02/2006EP1478380B1 Use of tyrosine kinase inhibitors for treating cns disorders
08/02/2006EP1450843B1 Use of thymulin-like peptides for making pain-relieving medicines
08/02/2006EP1430050B1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity
08/02/2006EP1412362B1 THIENO¬2,3-d|PYRIMIDINEDIONES AS INHIBITORS OF T-CELLS PROLIFERATION
08/02/2006EP1395242B1 Liquid pharmaceutical composition
08/02/2006EP1330459B1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders
08/02/2006EP1274692B1 Quinazoline compounds
08/02/2006EP1267828B1 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients
08/02/2006EP1246616B1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
08/02/2006EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
08/02/2006EP1210341B1 Compositions and therapeutic methods involving isoflavones and analogues thereof
08/02/2006EP1165137B1 Sphingomyelin containing preparation for the enhancement of tumor therapy
08/02/2006EP1133476B1 Iminoguanidine derivatives, preparation method, use as medicines
08/02/2006EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
08/02/2006EP1001785B1 Use of colchinol derivatives as vascular damaging agents
08/02/2006EP0866713B1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
08/02/2006CN1812973A Indazole compounds useful as protein kinase inhibitors
08/02/2006CN1812805A Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity
08/02/2006CN1812802A Formulations for the treatment of arhritis conditions
08/02/2006CN1812787A 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
08/02/2006CN1810958A Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin
08/02/2006CN1810822A 2-aminocarbonyl-9h-purine derivatives
08/02/2006CN1810794A Prepn process and medicine composition of dewatered andrographolide
08/02/2006CN1810286A Externally applied plaster
08/02/2006CN1810284A Yunnan Rhizoma Paridis extract and its prepn, medicinal use and medicine composition
08/02/2006CN1810280A Medicine composition for treating rheumatism, rheumatoidal diseases, etc. and its prepn process
08/02/2006CN1810276A Externally applied medicinal wine for treating rheumatism
08/02/2006CN1810267A Puerariae Decoction mixture preparing process
08/02/2006CN1810238A Oral arginine prepn for preventing and treating cachexia syndrome
08/02/2006CN1267550C Vascular endothelial growth factor 2
08/02/2006CN1267451C Somatostatin analogues
08/02/2006CN1267423C Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists
08/02/2006CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
08/02/2006CN1267394C Vitamin D analogues
08/02/2006CN1267117C Chinese medicine composition for curing traumatic injury and pains in chest and hypochondrium and its preparing method
08/02/2006CN1267108C Medication for treating painful symptoms of the illness
08/02/2006CN1267107C Extraction method of scorpion active protein liquid
08/02/2006CN1267098C Usage of treating allergic rhinitis and other disorders using descarboethoxyloratadine
08/02/2006CN1267087C Pharmaceutical tablet
08/02/2006CN1267024C Tryptophan source from plants and uses therefor
08/01/2006US7084172 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics
08/01/2006US7084161 Method for treating inflammatory diseases or conditions
08/01/2006US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
08/01/2006US7084148 Analgesics; antipyretics; antiinflammatory agents
08/01/2006US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
08/01/2006US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
08/01/2006US7084122 Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents
08/01/2006US7084117 Anticancer/tumor/scarring agents
08/01/2006US7084113 comprises a successfully elucidated crystal structure of a glycoprotein-binding protein originating from snake venom
08/01/2006US7084109 FVIIa antagonists
08/01/2006US7083965 Polypeptides, polynucleotides; hybrids; culture product
08/01/2006US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities
08/01/2006US7083785 Tumor necrosis factor family and its blocking agent
08/01/2006CA2379903C Novel benzotriazoles anti-inflammatory compounds
08/01/2006CA2277990C 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
08/01/2006CA2255668C Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
08/01/2006CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors
07/2006
07/28/2006CA2497820A1 A cream formulation of steroid and diphenhydramine
07/27/2006WO2006079077A2 Use of diltiazem or analogs thereof as modulators of ghrelin receptor
07/27/2006WO2006078907A1 2-substituted benzimidazole derivatives as vanilloid receptor ligands and their use in treatments
07/27/2006WO2006078834A1 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
07/27/2006WO2006077497A1 Crystalline forms cis-5-fluoro-n-[4-(2-hydroxy-4-methylbenzamido) cyclohexyl]-2-(tetrahydrothiopyran-a-yloxy) nicotinamide
07/27/2006WO2006077412A1 Thienopyrroles useful in the treatment of inflammation
07/27/2006WO2006077401A1 Pyrrolopyridines useful in the treatment of inflammation
07/27/2006WO2006077367A1 Indoles useful in the treatment of inflamation
07/27/2006WO2006077366A1 Indoles useful in the treatment of inflammation
07/27/2006WO2006077365A1 Indoles useful in the treatment of inflammation
07/27/2006WO2006077364A1 Indoles useful in the treatment of inflammation
07/27/2006WO2006077168A1 Pyrazolopyridines, their preparation and their medical use
07/27/2006WO2006076844A1 Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof
07/27/2006WO2006044582A3 Use of baff to treat sepsis
07/27/2006WO2005114206A3 Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a)
07/27/2006WO2005097090A3 AGENTS THAT DISRUPT PSD95 - nNOS INTERACTION, COMPOSITIONS CONTAINING THE SAME, AND THERAPEUTIC USES THEREOF
07/27/2006US20060168672 B7-like molecules and uses thereof
07/27/2006US20060167267 Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and the conversion of a ester moiety into an amino moiety; S)-2-methylcysteine; desferrithiocin
07/27/2006US20060167261 e.g. N-(4-Chloro-3-trifluoro methyl phenyl)-2-[3-(4-pyridinyloxy)phenyl amino]-acetamide; serine/threonine kinase inhibitor; anticarcinogenic, antiproliferative, antidiabetic agent; autoimmune diseases; atherosclerosis, arthritis, Crohn's disease, retinopaty
07/27/2006US20060167251 CCR9 inhibitors and methods of use thereof
07/27/2006US20060167086 Medicinal composition
07/27/2006US20060167083 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
07/27/2006US20060167082 4-Nitrooxybutyl 4-(2,6-Dichlorophenylamino)-thiophen-3-ylacetate; cytoprotective nitric oxide releasing nonsteroidal antiinflammatory agents; cyclooxygenase inhibitors; reduced side effects
07/27/2006US20060167062 Enema preparation
07/27/2006US20060167052 Piperidine derivative, process for producing the same, and use
07/27/2006US20060167049 Terphenly derivatives, preparation thereof, compositions containing same
07/27/2006US20060167048 N-4-piperidinyl compounds as ccr5 modulators
07/27/2006US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
07/27/2006US20060167038 2E)-3-{3-cyano-4,6-dimethyl-1-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1H-pyrrolo[2,3-b]pyridin-2-yl}-N-(3,4-dimethoxyphenyl)prop-2-enamide; preventive, therapeutic agent and analgesic for overactive bladder
07/27/2006US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor
07/27/2006US20060167011 Inhibitors of phosphorylation of platelet derived growth factor receptor
07/27/2006US20060167007 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
07/27/2006US20060167003 Probucol derivatives
07/27/2006US20060167002 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
07/27/2006US20060166996 Phthalazine derivatives as phosphodiesterase 4 inhibitors
07/27/2006US20060166990 Novel aminobenzophenone compounds
07/27/2006US20060166989 2-naphthamide derivatives
07/27/2006US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct
07/27/2006US20060166961 Cell adhesion inhibitors
07/27/2006US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases